Yossi Maimon Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yossi Maimon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yossi Maimon. Yossi Maimon is VP, Chief Financial Officer in Protalix BioTherapeutics, Inc. ($PLX).
Latest Insider Trading Transactions of Yossi Maimon
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 77,769 | 75,591 | 75,964 | |
| Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Payment of Exercise | F | 9.73 | 7,769 | 75,592 | 0 | 7.8 K to 0 (-100.00 %) |
| Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 77,769 | 75,591 | 0 | -77,769 to 0 (-100.00 %) |
| Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 9.67 | 70,000 | 676,900 | 0 | 70 K to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 70,000 | 68,040 | 153,733 | |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 70,000 | 68,040 | 0 | -70,000 to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 8.16 | 31,500 | 257,040 | 0 | 31.5 K to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 8.00 | 38,500 | 308,000 | 0 | 38.5 K to 0 (-100.00 %) |
| Feb 26 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | A | 6.90 | 130,000 | 897,000 | 130,000 | |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 167,698 | 163,002 | 223,733 | |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Payment of Exercise | F | 9.21 | 17,698 | 162,999 | 0 | 17.7 K to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 167,698 | 163,002 | 0 | -167,698 to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 9.35 | 40,300 | 376,805 | 0 | 40.3 K to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 9.50 | 109,700 | 1,042,150 | 0 | 109.7 K to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 62,217 | 60,475 | 391,431 | |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Payment of Exercise | F | 4.95 | 12,217 | 60,474 | 0 | 12.2 K to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 62,217 | 60,475 | 0 | -62,217 to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 5.01 | 10,000 | 50,100 | 0 | 10 K to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 5.13 | 40,000 | 205,200 | 0 | 40 K to 0 (-100.00 %) |
| May 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 40,348 | 39,218 | 453,648 | |
| May 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 4.00 | 30,000 | 120,000 | 0 | 30 K to 0 (-100.00 %) |
| May 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Payment of Exercise | F | 3.79 | 10,348 | 39,219 | 30,000 | 40.3 K to 30 K (-25.65 %) |
| May 19 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 40,348 | 39,218 | 40,348 | 0 to 40.3 K |
| Feb 27 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | A | 2.65 | 50,000 | 132,500 | 50,000 |
Page: 1